Mendoza-Pinto, Claudia <br/><br/>
The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus.  [electronic resource] 

 -  Clinics (Sao Paulo, Brazil)  Dec 2013 
 - 1475-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1980-5322 
<br/><br/><label>Standard No.: </label>10.6061/clinics/2013(12)01  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Cervix Uteri--cytology<br/>Cross-Sectional Studies<br/>DNA, Viral<br/>Female<br/>Genotype<br/>Glucocorticoids--adverse effects<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Logistic Models<br/>Lupus Erythematosus, Systemic--complications<br/>Mexico--epidemiology<br/>Middle Aged<br/>Papillomavirus Infections--chemically induced<br/>Polymerase Chain Reaction<br/>Prevalence<br/>Risk Factors<br/>Rituximab<br/>Socioeconomic Factors<br/>Uterine Cervical Diseases--chemically induced<br/>Vaginal Smears